News from lexicon pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 29, 2015, 16:02 ET

Lexicon Announces One For Seven Reverse Stock Split Effective May 20, 2015

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it will effect a reverse stock split at a ratio of one share of newly issued...

Apr 29, 2015, 16:01 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Apr 27, 2015, 16:30 ET

Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Apr 15, 2015, 07:00 ET

Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Apr 09, 2015, 08:00 ET

Lexicon To Present At Needham & Company's 14th Annual Healthcare Conference

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at Needham & Company's 14th Annual Healthcare...

Mar 25, 2015, 08:00 ET

Lexicon Pharmaceuticals Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Mar 18, 2015, 08:30 ET

Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement for Telotristat Etiprate to Include Canada

-- Lexicon eligible for an additional $5 million in up-front and pre-commercial milestone payments for Canadian rights, plus royalties and sales...

Mar 09, 2015, 08:00 ET

Lexicon Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Telotristat Etiprate

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Mar 04, 2015, 07:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Mar 02, 2015, 07:30 ET

Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Feb 26, 2015, 08:00 ET

Lexicon To Present At The Cowen 35th Annual Health Care Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Cowen 35th Annual Health Care...

Feb 23, 2015, 16:30 ET

Lexicon Announces Management Change

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today the resignation of Brian P. Zambrowicz, Ph.D., executive vice president and chief...

Feb 06, 2015, 16:05 ET

Lexicon To Present At The BIO CEO & Investor Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the BIO CEO & Investor Conference on...

Jan 07, 2015, 16:30 ET

Lexicon To Present At The 33rd Annual J.P. Morgan Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 33rd Annual J.P. Morgan Healthcare...

Dec 08, 2014, 18:02 ET

Lexicon To Present At The Oppenheimer 25th Annual Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Oppenheimer 25th Annual Healthcare...

Nov 26, 2014, 16:01 ET

Lexicon Announces Completion Of $280 Million In Financing Transactions

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the completion of previously announced concurrent financing transactions resulting in...

Nov 21, 2014, 01:00 ET

Lexicon Announces Pricing Of Common Stock Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the pricing of its previously announced underwritten public offering of...

Nov 21, 2014, 01:00 ET

Lexicon Announces Pricing Of Convertible Senior Notes Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has priced its offering of $80,000,000 aggregate principal amount of...

Nov 19, 2014, 16:01 ET

Lexicon Announces Proposed Convertible Senior Notes Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it commenced an offering to sell, subject to market and other conditions,...

Nov 19, 2014, 16:01 ET

Lexicon Announces Proposed Common Stock Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it commenced an offering to sell, subject to market and other conditions,...